Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium

Alterity Therapeutics Limited - American Depositary Shares (ATHE)

MELBOURNE, Australia and SAN FRANCISCO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the presentation of data from Alterity’s Biomarkers of progression in Multiple System Atrophy (bioMUSE) natural history study at the 35th International Symposium on the Autonomic Nervous System. “The data presented highlights our work to better understand not only how multiple system atrophy (MSA) initially presents, but also how it progresses over time,” said David Stamler, M.D., Chief Executive Officer of Alterity. “The presentation describes the use of state-of-the-art technology that goes beyond traditional MRI methods to track the change in volume in specific regions of the brain affected in patients with MSA. Importantly, we observed that significant reductions in brain volume over 12 months correlat Show less Read more

Download PDF

Impact Snapshot

Event Time:

ATHE

Last Price

Price Change

Price Change%

Volume Shares

Max Up

Max Down

Volume Ratio

Performance Comparison Updated

Event Day Stock performance from the time of news release until the following 4pm ET market close	Last price at news event	Since Event Multi-day stock performance from the time of the news release
EVENT DAY Stock performance from the time of news release until the following 4pm ET market close	LAST PRICE AT NEWS EVENT	SINCE EVENT Multi-day stock performance from the time of the news release
	Last Price
	VWAP
High:	Max Up	High:
Low:	Max Down	Low:

%	Post news range	%
	Price change
	Price Change Percentage
	S&P 500 (SPX)
%	Volume ratio	%
	Volume
	Ticks
	Avg transaction size

Don't Miss Out On The Next BIG Stock Move

Event day

Event Day Chart will not be displayed beyond 90-day period of the event

Performance since event

Time And Velocity Analysis

Opt-in for ATHE alerts

ATHE News

ATHE Earnings

ATHE Analyst Actions

ATHE Sec Filings

ATHE's page on the SEC website

Opt-in for
ATHE alerts

from News Quantified

Opt-in for
ATHE alerts

from News Quantified

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed

Opt in for alerts from News Quantifed